Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Neuroendocrine tumours of the gastrointestinal tract cause carcinoid syndrome and carcinoid heart disease. These tumours secrete serotonin, which can bind to heart valves and cause fibrosis and valve incompetence. Most cases involve the tricuspid valve +/- pulmonary valve. Medical management comprises diuretics for fluid overload and somatostatin analogues to reduce circulating serotonin. Definitive treatment is heart-valve replacement surgery which improves exercise tolerance but has high perioperative mortality. We have previously reported that valve-replacement surgery can reduce 5-hydroxyindoleacetic acid (5-HIAA) levels, reflecting a decline in hormone activity.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Shah H
Authors: Shah H, Sagar V, Venkataraman H, Steeds R, Rooney S,
Keywords: carcinoid, carcinoid syndrome, neuroendocrine tumour, carcinoid heart disease, 5hiaa,
Introduction: There is limited previous data on Peptide receptor radiotherapy (PRRT) in pheochromocytoma (PCC) and paraganglioma (PGL).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Vyakaranam A
Authors: Vyakaranam A, Crona J, Thiis-Evensen E, Hellman P, Norlén O,
Keywords: PRRT, 177Lu-DOTATATE, Pheochromocytoma, Paraganglioma,
Introduction: PET/CT imaging of patients with neuroendocrine neoplasms (NEN) 1 hour (h) post injection (pi) of 64Cu-DOTATATE has shown superiority in lesion detection when compared to other clinically available somatostatin receptor imaging (SRI) modalities.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Loft M, Johannesen H, Carlsen E, Johnbeck C, Binderup T,
Keywords: 64Cu-DOTATATE, Neuroendocrine Neoplasms, PET Imaging, Somatostatin Receptor Imaging,
Introduction: There are several treatment modalities for unresectable neuroendocrine tumors. Traditionally the goal of these treatments are to reduce the tumor load; objective response (OR). Less emphasis has been put on inducing the tumors to stop growing without reduction in total tumor load; stable disease (SD).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Thiis-Evensen E
Authors: Thiis-Evensen E, Sponheim J,
Keywords: Neuroendocrine tumor, Treatment, Radiology, Time to progression,
#2295 Results of Liver Transplantation in Patients with Neuroendocrine Tumors
Introduction: liver transplantation (LTx) for patients with neuroendocrine tumors (NET) is a option for patients con metastasis limited to the liver. The main indication is when the metastatic NET of the liver not accessible to surgery or reduction.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Percovich J, García R, Romero M, Blanco M, Torres G,
Keywords: Liver transplant, Neuroendocine tumors, Time of recurrence,